B Bernstein
Broad Institute
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Genomics and Chromatin Dynamics
Strong evidence · 4 supporting papers · latest 2026
Ubiquitin and proteasome pathways
Strong evidence · 1 supporting paper · latest 2025
Cancer Research and Treatments
Strong evidence · 1 supporting paper · latest 2025
Glioma Diagnosis and Treatment
Strong evidence · 3 supporting papers · latest 2026
Lung Cancer Research Studies
Strong evidence · 1 supporting paper · latest 2025
Chromatin Remodeling and Cancer
Strong evidence · 1 supporting paper · latest 2025
Peptidase Inhibition and Analysis
Strong evidence · 1 supporting paper · latest 2025
MicroRNA in disease regulation
Strong evidence · 1 supporting paper · latest 2025
Publications (15)
Loss of NOTCH2 creates a TRIM28-dependent vulnerability in small cell lung cancer
2025DOIPMID 40865518
In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy target
2025DOIPMID 41022734
Mutant IDH silences GSX2 to reprogram neural progenitor cell fate and promote gliomagenesis
2025DOIPMID 40832272
High-throughput in silico screen uncovers key regulators of 3D genome architecture
2025DOIPMID 41415375
Mapping active cis-regulatory elements from transcription initiation events
2026DOI
Chromatin topology and distal elements underlie divergent cell-type-specific regulation of 9p21 locus cell cycle genes
2026DOIPMID 42520801
TMOD-12. Preclinical and clinical assessment of chemoradiation after mutant IDH inhibitor treatment in IDH-mutant glioma
2025DOI
An expanded registry of candidate cis-regulatory elements
2026DOIPMID 41501460
Abstract 837: IDH mutations disable the tumor suppressive activity of GSX2 to promote gliomagenesis.
2026DOI
Loss of tumor-infiltrating lymphocytes and poor response to immunotherapy in IDH GOF mutant melanoma
2026DOIPMID 41955022
Metastatic Osteosarcoma is Characterized by Loss of Osteoblastic Lineage Fidelity
2026DOI
Abstract PR001: Exploiting HIF-driven endogenous retroviral neoantigens to advance kidney cancer immunotherapy
2026DOI
Multiomic analyses delineate human neuroendocrine tumor cell states in relation to normal enteroendocrine cell ontogeny
2026DOIPMID 42166365
High-throughput single-cell methylation resolves epigenetic states in hematopoietic differentiation and age-related clonal expansions
2025DOI
119 Endogenous retroviruses as tumor-specific antigens in clear cell renal cell carcinoma: A new avenue for immunotherapy
2025DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Broad Institute
- Dana-Farber Cancer Institute
Source: OpenAlex · retrieved 2026-09-29
Source: ScienceWe Extractor · retrieved 2026-09-27